Sympathetic Denervation for Treatment of Ventricular Arrhythmias

J Atr Fibrillation. 2020 Jun 30;13(1):2404. doi: 10.4022/jafib.2404. eCollection 2020 Jun-Jul.

Abstract

Ventricular arrhythmias are a major cause of morbidity and mortality in patients with heart disease. A growing understanding of the cardiac autonomic nervous system's crucial role in the pathogenesis of ventricular arrhythmias has led to the development of several neuromodulation therapies. Sympathetic neuromodulation is being increasingly utilized to treat ventricular arrhythmias refractory to medical therapy and catheter ablation. There is a growing body of preclinical and clinical evidence supporting the use of thoracic epidural anesthesia, stellate ganglion blockade, cardiac sympathetic denervation, and renal denervation in the treatment of recurrent ventricular arrhythmias. This review summarizes the relevant literature and discusses approaches to sympathetic neuromodulation, particularly in the management of scar-related ventricular arrhythmias.

Keywords: Autonomic Modulation; Sympathetic Denervation; Ventricular Tachycardia.